Stanford University School of Medicine

Redwood City, California 94305

1 studies enrolling now · 15 studies all time

What they study most

Alopecia Areata, Bariatric Surgery Candidate, Celiac Disease, Cirrhosis, Cutaneous T-cell Lymphoma, Gastroparesis, Hepatic Encephalopathy, Hepatitis D, Chronic, IBS - Irritable Bowel Syndrome, Multiple Sclerosis, Chronic Progressive, Obesity, Morbid, Plaque-type Psoriasis

Studies at this site

• A Study of JNJ-73763989 + Nucleos(t)Ide Analog in Participants Co-Infected With Hepatitis B and Hepatitis D Virus — Completed
• Using Digital Health Technology to Monitor Patients With Primary Biliary Cholangitis (PBC) — Enrolling by invitation
• Phase 2a Evaluation of Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Patients With Primary Sclerosing Cholangitis (PSC) — Completed
• A Study of TAK-062 in Treatment of Active Celiac Disease in Participants Attempting a Gluten-Free Diet — Completed
• Zemedy Application for Irritable Bowel Syndrome — Stopped early
• Safety and Efficacy of Repeated Administration of NurOwn (MSC-NTF Cells) in Participants With Progressive MS — Completed
• Study to Intervene With Nutrition for Gastroparesis — Stopped early
• ENHANCE: Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Response to or an Intolerance to Ursodeoxycholic Acid (UDCA) — Completed
• Study to Evaluate the Safety and Efficacy of CTP-543 in Adults With Moderate to Severe Alopecia Areata — Completed
• A Study to Evaluate the Efficacy and Safety of VX-150 in Treating Subjects With Pain Caused by Small Fiber Neuropathy — Completed
• Eye Movement Testing in Patients With Obesity and the Impact of Weight Loss Surgery — Stopped early
• Eye Movement Testing for Diagnosing Encephalopathy in Patients With Liver Disease — Stopped early
• Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study) — Completed
• Study of Pralatrexate in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma — Completed
• Safety and Tolerability of Pirfenidone in Participants With Systemic Sclerosis-Related Interstitial Lung Disease (SSc-ILD) (LOTUSS) — Completed